v3.26.1
EMPLOYEE BENEFITS
12 Months Ended
Jan. 31, 2026
EMPLOYEE BENEFITS [Abstract]  
EMPLOYEE BENEFITS
10.EMPLOYEE BENEFITS

 

Until its expiration on June 1, 2025 the Company maintained the REX American Resources Corporation 2015 Incentive Plan, approved by its shareholders, which reserved a total of 3,300,000 split-adjusted shares of common stock for issuance pursuant to its terms. The plan provided for the granting of shares of stock, including options to purchase shares of common stock, stock appreciation rights tied to the value of common stock, restricted stock, and restricted stock unit awards to eligible employees, non-employee directors and consultants. Until 2022, the Company had only granted restricted stock awards.  In May 2022, the Company issued restricted stock units to certain officers of the Company which vested based on the Company’s TSR compared to the TSRs of companies that comprise the Russell 2000 Index over a three-year performance period (see below). The Company measures share-based compensation grants at fair value on the grant date, adjusted for estimated forfeitures. The Company records non-cash compensation expense related to equity awards in its consolidated financial statements over the requisite service period on a straight-line basis. At the time of its expiration, 1,065,809 shares (pre-2025 split) remained available for issuance under the Plan.

Restricted Stock Awards

 

As a component of their compensation, restricted stock has been granted to directors and certain employees at the closing market price of REX common stock on the date of the grant. In addition, one-quarter of executives’ incentive compensation is payable by an award of restricted stock based on the then market price of REX common stock on the date of grant. The Company’s board of directors has determined that the grant date will be June 15th, or the next business day, for all grants of restricted stock.

 

Based on retirement eligibility provisions, a portion of restricted stock grants are expensed at grant date, based on grant date fair value, thus considered vested for accounting purposes. At January 31, 2026, 20,964 shares were unvested for accounting purposes and unrecognized compensation cost related to these nonvested restricted stock awards was approximately $245,000, to be recognized over a weighted average vesting term of 1.2 years.

 

The following table summarizes legally non-vested restricted stock award activity for fiscal years 2025, 2024, and 2023:

 

   2025 
    Non-Vested
Shares
    Weighted
Average Grant
Date Fair Value
(000’s)
    Weighted
Average Remaining
Vesting Term
(in years)
 
Non-Vested at January 31, 2025   324,784   $6,190    2 
Granted   -    -      
Forfeited   -    -      
Vested   164,420    2,946      
                
Non-Vested at January 31, 2026   160,364   $3,244    1 
                
   2024 
   Non-Vested
Shares
   Weighted
Average Grant
Date Fair Value
(000’s)
   Weighted
Average Remaining
Vesting Term
(in years)
 
Non-Vested at January 31, 2024   325,710   $5,369    2 
Granted   126,814    2,894      
Forfeited   -    -      
Vested   127,740    2,073      
                
Non-Vested at January 31, 2025   324,784   $6,190    2 
   2023 
   Non-Vested
Shares
   Weighted
Average Grant
Date Fair Value
(000’s)
   Weighted
Average Remaining
Vesting Term
(in years)
 
Non-Vested at January 31, 2023   162,528   $2,320    2 
Granted   227,452    3,945      
Forfeited   -    -      
Vested   64,270    896      
                
Non-Vested at January 31, 2024   325,710   $5,369    2 

 

Restricted Stock Units

 

In May 2022, the Company issued a total of 135,000 RSUs to certain officers with a performance period that ended on December 31, 2024. The number of RSUs eligible to vest ranged from zero percent to two-hundred percent and was determined based on how the Company’s TSR compared to the TSR of companies that comprise the Russell 2000 Index during the performance period. The calculated payout of the RSUs that vested was 148%, or 199,800 shares of REX common stock, and the shares were issued on February 26, 2025.

 

The Company did not recognize any compensation cost related to RSUs for the year ended January 31, 2026. For the years ended January 31, 2025 and 2024, the Company recognized compensation cost of approximately $0.9 million and $1.1 million, respectively, related to RSUs. There was no unrecognized compensation cost related to nonvested RSUs at January 31, 2026 and 2025, respectively.

 

At January 31, 2024, we calculated the diluted weighted average shares as follows (amounts in thousands):

 

Weighted average shares - basic 34,964
Dilutive effect of RSUs 187
Weighted average shares - diluted 35,151